We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now.
Abbott Laboratories (NYSE:ABT) is one of the best healthcare stocks on our list
TheFly reported on July 6 that Evercore ISI analyst Vijay Kumar reduced the firm’s price target on Abbott Laboratories to $112 from $120 while maintaining an Outperform rating on the shares. The updated target was included in the firm’s second-quarter outlook for the MedTech, Life Sciences Tools, and Diagnostics industries. Evercore ISI noted that sector conditions remain supported by relatively healthy procedure volumes and capital spending trends, according to a research note shared with investors.
Earlier on July 1, Tandem Diabetes Care announced that its t: slim X2 insulin pump featuring Control-IQ+ automated insulin delivery technology is now compatible with Abbott Laboratories (NYSE:ABT)’s FreeStyle Libre 3 Plus continuous glucose monitoring sensor across five countries. The expansion provides users in the United Kingdom, Switzerland, Sweden, Finland, and Italy with additional CGM options while using Tandem’s automated insulin delivery system. The company expects to broaden availability to more European markets, including Belgium, the Netherlands, and Germany, during 2026.